N |
21 |
169 |
— |
Preoperative characteristics |
|
|
|
Age, years |
30.5 (23-34.8; 19-56) |
38 (26-53; 19-70) |
0.048 |
Male gender |
13 (61.9) |
99 (58.6) |
0.770 |
Body mass index, kg/m2
|
20.2 (19-23; 17.7-27.9) |
20.6 (18.9-24.2; 15.8-58.1) |
0.586 |
Hemoglobin, g/L |
84 (78-91; 71-103) |
132 (115-146; 70-196) |
<0.001 |
Hemoglobin <90 g/L |
16 (76.2) |
9 (5.3) |
<0.001 |
Platelet count, x109/L |
153 (84-257; 37-550) |
293 (217-376; 52-659) |
<0.001 |
Platelet count <150 x109/L |
11 (52.4) |
14 (8.3) |
<0.001 |
aPTT, seconds |
49.5 (43.8-66.2; 34.5-97.1) |
31.9 (29.5-34.6;
21.4-108) |
<0.001 |
INR |
1.2 (1.1-1.4; 0.9-1.7) |
1.0 (1.0-1.1; 0.8-2.5) |
<0.001 |
Creatinine, µmol/L |
58 (33-70; 19-94) |
57 (46-69.5; 27-142) |
0.333 |
FVC, L |
1.62 (1.36-2.18; 0.73-3.23) |
1.83 (1.35-2.33; 0.39-4.98) |
0.561 |
FEV1, L |
0.97 (0.62-1.36; 0.41-2.30) |
0.78 (0.63-0.99; 0.28-3.21) |
0.217 |
Renal replacement therapy |
1 (4.8) |
1 (0.6) |
0.168 |
Mechanical ventilation |
8 (38.1) |
0 |
— |
Diagnosis |
|
|
|
Cystic fibrosis |
19 (90.5) |
108 (63.9) |
0.015 |
α1-antitrypsin deficiency |
1 (4.8) |
34 (20.1) |
0.087 |
Pulmonary fibrosis/ILD |
1 (4.8) |
27 (16.0) |
0.171 |
Preoperative ECMO duration (days) |
8 (6.5-16; 1-52) |
— |
— |
Intraoperative characteristics |
|
|
|
Bilateral lung transplant |
21 (100) |
162 (95.9) |
— |
Cardiopulmonary bypass |
6 (28.6) |
60 (35.5) |
0.529 |
ECMO |
15(71.4) |
12 (7.1) |
<0.001 |
Transfusion (24h) |
|
|
|
Red blood cells, units |
13.5 (8.2-41.8; 5-53) |
4.0 (2.0-8.0; 0-71) |
<0.001 |
Platelets, pools |
3.5 (1.2-8.5; 0-21) |
1.0 (0-2.0; 0-18) |
<0.001 |
Fresh frozen plasma, units |
6 (2.5-11; 0-37) |
2.0 (0-4.5; 0-32) |
<0.001 |
Cryoprecipitate, units |
8 (38.1) (median 3.5 units) |
27 (16.0)
(median 2 units) |
0.023 |